First floor

Campania, new decree obliges doctors to justify the prescribed "branded" recipes

It risks being boycotted by pharmacies of the territory the decree of the Campania Region which obliges doctors to justify, with a form prepared by the pharmaceutical service, the "branded" recipes prescribed under the reimbursement regime. Approved at the end of May but only released yesterday, the provision of the Region expressly aims to increase the consumption of generics, in order to make savings on pharmaceutical expenditure which, "from the prescriptive appropriateness indicators monitored in the Ts dashboard (health card, ed.)", would exceed 66 million euros.

To achieve the goal, the decree requires the Local Health Authorities bells to align the rates of prescriptions with generics to those of "the most virtuous health authority in Campania". This means, to give some examples, that they must concern a generic 72% of the ddds (defined doses per day) of ACE inhibitors associated with diuretics, 87% of the ddds of angiotensin II antagonists, 82% of the ddds of Hmg CoA reductase, fluoroquinolone ddd 83% and so on.

For this purpose, the regional provision obliges doctors to favor "off patents" in all prescriptions addressed to "naïve" patients, ie when starting a new pharmacological therapy. And to ensure that the provision is observed, it prescribes that in the case of a prescription for a "branded" drug, the doctor must fill in a «Single prescription model» in which to detail the clinical reasons that impose the choice of the brand specialty.

The annoyances, however, are not limited to doctors. In fact, the decree asks local pharmacists to evaluate the arguments provided by the doctor in the "Model" and, in the event of insufficient motivation, to invite the prescriber to integrate the form. Worse still, in the event of a refusal by the latter, the pharmacist should report the case "to his own strategic management, which will proceed to impose (the doctor, ed.) the sanctions envisaged by current legislation". But that's not enough: the decree remains rather smoky on the fate of the recipe in the event of a dispute; the pharmacist is authorized to send it anyway, but there is no explicit indication that guarantees the subsequent reimbursement to the holder.

Hence the letter which, a few hours after publication of the provision on the Bur, the president of Federfarma Campania Michele Di Iorio sent to the commissioner structure of the Region. Not only to have certainties regarding the payment of the drugs dispensed, but also to remember that "pharmacy owners do not want and must not express "censures"" against the "documentary presentations drawn up by family doctors". Put simply, pharmacies will not apply the decree.

AS – Federfarma – 01/07/2015

Related news: Doctors obliged to write in capital letters to avoid errors

Decree 56 on designer drugs suspended: victory for doctors and pharmacists

Decree 56, which required the doctor to fill in a form for the purchase of branded drugs for those patients who do not want the generic, has been suspended.
Yesterday a meeting was held at the Commissioner's Structure of the Campania Region in the presence of the sub commissioners Morlacco, Cinque and the union representatives of doctors and pharmacists. Dr. Caiffa, provincial president of Snami explains: "In this meeting numerous critical issues emerged regarding the applicability of this decree, therefore it was decided to set up a discussion table as soon as the new commissioner is appointed, to make changes and reach a solution also shared with the pharmacists of the Campania Region.

In the meantime, it will not be mandatory to attach the single prescription form to the recipe". Against decree 56, Michele Di Iorio, president of Federfarma and Giusepe Tortora and Saverio Annunziata, national managers of Sumai in general medicine, took to the warpath.

Saturday 11 July 2015 – THE MORNING Naples Chronicle

Redazione Fedaiisf

Promote the cohesion and union of all members to allow a univocal and homogeneous vision of the professional problems inherent in the activity of pharmaceutical sales reps.

Articoli correlati

Back to top button
Fedaiisf Federazione delle Associazioni Italiane degli Informatori Scientifici del Farmaco e del Parafarmaco